SAVE THE DATE - BioTrinity 2015 - 11-13th May

 

BioTrinity 2015 - European Biopartnering and Investment Conference - May 11-13, 2015

Where Great MindsSmart Money and Key Dealmakers Meet

BioTrinity is the Leading European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other key European partnering conference. BioTrinity 2015 will build on its established reputation as the largest UK-focused biopartnering and investment conference, the powerhouse of partnering which brings together a critical mass of active investors, global pharma and innovative biotech and medtech companies.

BioTrinity is venturing to central London in 2015, taking place at the Novotel London West, the flagship hotel of the Accor Group, located just 30 minutes travel time from Heathrow with plentiful hotel accommodation in the area.

To read more about BioTrinity 2014, and hear what our delegates had to say, please scroll down.

Delegates met with the key licensing contacts from large corporates including AbbVie, Amgen, Astellas, AstraZeneca, Boehringer,  Bristol-Myers Squibb, Chiesi, Eli Lilly, Genzyme, GE, GSK, J&J, Life Technologies, Linde AG, MSD, Novartis, Novo Nordisk, Sanofi-Aventis, Sanofi-Pasteur, Shire, Pfizer, Roche, Takeda as well as mid-sized including Vertex, Ferrer, Actelion, MorphoSys, Nordic Pharma, Norgine, Qiagen, QuantuMDx and other senior BD&L execs

Delegates met with 100 delegates from active VC and Corporate Venture firms including MedImmune Ventures, SR One, JJDC, AbbVie Inc, Mitsui & Co.MPH Ventures, Norgine Ventures, Novartis Venture Fund, MS Ventures, MRL Venture Fund, Takeda Ventures, Unilever Ventures, Boehringer Ingelheim Ventures, Inventages, as well as Lundbeckfond Ventures, Novo A/S, Syncona, Index, Sofinnova, EdRIP and many international VCs

The Company Showcases were a unique hand-picked crop of early-stage companies that delegates haven't seen elsewhere

Thanks to EBD Group's partneringONE®, the industry gold-standard partnering system with entirely private partnering: 

partneringOne

You need to upgrade your Flash Player


The "Event of the Year" - BioTrinity 2014:

Huge partnering potential with global pharma / investors

 100 presentations by hand-picked R&D companies

 Innovative "Connect for Growth" zones that encouraged informal and formal collaborative interactions

Great networking opportunities with 1000 delegates

 First class venue at Novotel London West

Exciting Social Programme:

 The Big London Networking Party, BioTrinity Welcome Reception and Connect for Drinks

 Europe's Largest Investor-only Dinner

Check out the glowing testimonials we received for BioTrinity, or view the photos from the Gallery





BioTrinity 2013 highlights
877 delegates from 28 countries
520 companies
168 speakers
86 company presentations
1679 scheduled one-to-one meetings
97 investors from 11 countries
66 exhibitors
32 global pharma/corporate venture